The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
The PDGF/PDGFR pathway as a drug target
Abstract
Platelet-derived growth factors (PDGF) promotes cell proliferation, survival and migration, primarily of cells of mesenchymal origin. Dysfunction of PDGF signaling has been observed in a wide array of pathological conditions, such as cancer, fibrosis, neurological conditions and atherosclerosis. Reported abnormalities of the PDGF pathway include overexpression or amplification of PDGF receptors (PDGFRs), gain of function point mutations or activating chromosomal translocations. Current development of therapeutic drugs often aims at producing compounds that specifically target interaction between PDGFs and their receptors by specific DNA aptamers and ligand traps, or downregulate PDGFRs with blocking antibodies, or inhibit tyrosine kinase activity of PDGFRs with small molecules. In this review, we discuss some of the approaches taken to interfere with PDGF signaling, review a panel of existing therapeutic drugs, and consider clinically successful cases and remaining challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Role of platelet-derived growth factors in physiology and medicine
Andrae, J., Gallini, R., & Betsholtz, C. (2008) · Genes & Development · doi:10.1101/gad.1653708 · Cited by 2,438
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Organoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508
Insulator dysfunction and oncogene activation in IDH mutant gliomas
Flavahan, W. A., Drier, Y., Liau, B. B., Gillespie, S. M., Venteicher, A. S., Stemmer-Rachamimov, A. O., Suvà, M. L., & Bernstein, B. E. (2016) · Nature · doi:10.1038/nature16490 · Cited by 1,288
Hallmarks of cancer: Interactions with the tumor stroma
Pietras, K., & Östman, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.045 · Cited by 1,141
Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., & Ross, R. (1991) · Science · doi:10.1126/science.1653454 · Cited by 1,065
PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis
Boström, H., Willetts, K., Pekny, M., Levéen, P., Lindahl, P., Hedstrand, H., Pekna, M., Hellström, M., Gebre-Medhin, S., Schalling, M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81270-2 · Cited by 864
The PDGF family: four gene products form five dimeric isoforms
Fredriksson, L., Li, H., & Eriksson, U. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.007 · Cited by 838
Nanomedicine therapeutic approaches to overcome cancer drug resistance
Markman, J. L., Rekechenetskiy, A., Holler, E., & Ljubimova, J. Y. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.019 · Cited by 733
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718
PDGF-C is a new protease-activated ligand for the PDGF α-receptor
Li, X., Pontén, A., Aase, K., Karlsson, L., Abramsson, A., Uutela, M., Bäckström, G., Hellström, M., Boström, H., Li, H., et al. (2000) · Nature Cell Biology · doi:10.1038/35010579 · Cited by 623
Crawford, Y., Kasman, I., Yu, L., Zhong, C., Wu, X., Modrusan, Z., Kaminker, J., & Ferrara, N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.004 · Cited by 611
Roles of PDGF in animal development
Hoch, R. V., & Soriano, P. (2003) · Development · doi:10.1242/dev.00721 · Cited by 585
Tap, W. D., Jones, R. L., Van Tine, B. A., Chmielowski, B., Elias, A. D., Adkins, D., Agulnik, M., Cooney, M. M., Livingston, M. B., Pennock, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30587-6 · Cited by 584
Bork, P., & Beckmann, G. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1305 · Cited by 581
Ng, F., Boucher, S., Koh, S., Sastry, K. S. R., Chase, L., Lakshmipathy, U., Choong, C., Yang, Z., Vemuri, M. C., Rao, M. S., et al. (2008) · Blood · doi:10.1182/blood-2007-07-103697 · Cited by 580
PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor
Bergsten, E., Uutela, M., Li, X., Pietras, K., Östman, A., Heldin, C.-H., Alitalo, K., & Eriksson, U. (2001) · Nature Cell Biology · doi:10.1038/35074588 · Cited by 562
Targeting the PDGF signaling pathway in tumor treatment
Heldin, C.-H. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-97 · Cited by 540
Brennan, C., Momota, H., Hambardzumyan, D., Ozawa, T., Tandon, A., Pedraza, A., & Holland, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007752 · Cited by 534
Oligodendrocyte Population Dynamics and the Role of PDGF In Vivo
Calver, A. R., Hall, A. C., Yu, W.-P., Walsh, F. S., Heath, J. K., Betsholtz, C., & Richardson, W. D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80469-9 · Cited by 501
Lokker, N. A., Sullivan, C. M., Hollenbach, S. J., Israel, M. A., & Giese, N. A. (2002) · PubMed · Cited by 491
PDGF and cardiovascular disease
Raines, E. W. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.004 · Cited by 484
Pinzani, M., Gesualdo, L., Sabbah, G. M., & Abboud, H. E. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114363 · Cited by 478
Imatinib: A Breakthrough of Targeted Therapy in Cancer
Iqbal, N., & Iqbal, N. (2014) · Chemotherapy Research and Practice · doi:10.1155/2014/357027 · Cited by 470
Su, E. J., Fredriksson, L., Geyer, M., Folestad, E., Cale, J., Andrae, J., Gao, Y., Pietras, K., Mann, K., Yepes, M., et al. (2008) · Nature Medicine · doi:10.1038/nm1787 · Cited by 468
Pietras, K., Östman, A., SJÖQUIST, M., Buchdunger, E., Reed, R. K., Heldin, C., & Rubin, K. (2001) · PubMed · Cited by 450
Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice
Fruttiger, M., Karlsson, L., Hall, A. C., Abramsson, A., Calver, A. R., Boström, H., Willetts, K., Bertold, C.-H., Heath, J. K., Betsholtz, C., et al. (1999) · Development · doi:10.1242/dev.126.3.457 · Cited by 441
Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy.
Pietras, K., Rubin, K., Sjöblom, T., Buchdunger, E., Sjöquist, M., Heldin, C., & Östman, A. (2002) · PubMed · Cited by 433
Sasahara, M., Fries, J. W. U., Raines, E. W., Gown, A. M., Westrum, L. E., Frosch, M. P., Bonthron, D. T., Ross, R., & Collins, T. (1991) · Cell · doi:10.1016/0092-8674(91)90223-l · Cited by 413
PDGF-D, a new protease-activated growth factor
LaRochelle, W. J., Jeffers, M., McDonald, W. F., Chillakuru, R. A., Giese, N. A., Lokker, N. A., Sullivan, C., Boldog, F. L., Yang, M., Vernet, C., et al. (2001) · Nature Cell Biology · doi:10.1038/35074593 · Cited by 402
Inhibitory DNA Ligands to Platelet-Derived Growth Factor B-Chain
Green, L. S., Jellinek, D., Jenison, R., Östman, A., Heldin, C.-H., & Janjic, N. (1996) · Biochemistry · doi:10.1021/bi961544+ · Cited by 390
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
Abdollahi, A., Li, M., Ping, G., Plathow, C., Domhan, S., Kiessling, F., Lee, L. B., McMahon, G., Gröne, H.-J., Lipson, K. E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041393 · Cited by 388
(1992) · PubMed · Cited by 383
Specific Targeted Therapy of Chronic Myelogenous Leukemia with Imatinib
Deininger, M. W. N., & Druker, B. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.4 · Cited by 365
Philadelphia ChromosomePositive Leukemias: From Basic Mechanisms to Molecular Therapeutics
Kurzrock, R., Kantarjian, H. M., Druker, B. J., & Talpaz, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-10-200305200-00010 · Cited by 345
Thermosensitive liposomal drug delivery systems: state of the art review
Hossann, M., Kneidl, B., Peller, M., Lindner, L., & Winter, G. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s49297 · Cited by 342
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
Campbell, J. S., Hughes, S. D., Gilbertson, D. G., Palmer, T. E., Holdren, M. S., Haran, A. C., Odell, M. M., Bauer, R. L., Ren, H.-P., Haugen, H. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409722102 · Cited by 333
Jo, N., Mailhos, C., Ju, M., Cheung, E., Bradley, J., Nishijima, K., Robinson, G. S., Adamis, A. P., & Shima, D. T. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050588 · Cited by 322
Raica, M., & Cimpean, A. M. (2010) · Pharmaceuticals · doi:10.3390/ph3030572 · Cited by 304
Mejias, M., Garcia-Pras, E., Tiani, C., Miquel, R., Bosch, J., & Fernandez, M. (2009) · Hepatology · doi:10.1002/hep.22758 · Cited by 293
Platelet-derived Growth Factor C (PDGF-C), a Novel Growth Factor That Binds to PDGF α and β Receptor
Gilbertson, D. G., Duff, M. E., West, J. W., Kelly, J. D., Sheppard, P. O., Hofstrand, P. D., Gao, Z., Shoemaker, K., Bukowski, T. R., Moore, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101056200 · Cited by 292
Pinzani, M., Milani, S., Herbst, H., DeFranco, R., Grappone, C., Gentilini, A., Caligiuri, A., Pellegrini, G., Ngo, D. V., Romanelli, R. G., et al. (1996) · Europe PMC (PubMed Central) · Cited by 286
Uehara, H., Kim, S. J., Karashima, T., Shepherd, D. L., Fan, D., Tsan, R., Killion, J. J., Logothetis, C., Mathew, P., & Fidler, I. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.458 · Cited by 280
Fibroblasts as architects of cancer pathogenesis
Marsh, T., Pietras, K., & McAllister, S. S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.10.013 · Cited by 264
Davies, D. R., Gelinas, A. D., Zhang, C., Rohloff, J. C., Carter, J. D., O’Connell, D., Waugh, S. M., Wolk, S. K., Mayfield, W. S., Burgin, A. B., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213933109 · Cited by 256
Reigstad, L. J., Varhaug, J. E., & Lillehaug, J. R. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04989.x · Cited by 236
Robertson, K. A., Nalepa, G., Yang, F.-C., Bowers, D. C., Ho, C. Y., Hutchins, G. D., Croop, J. M., Vik, T. A., Denne, S. C., Parada, L. F., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70414-x · Cited by 234
Araujo, J. C., Trudel, G. C., Saad, F., Armstrong, A. J., Yu, E. Y., Bellmunt, J., Wilding, G., McCaffrey, J., Serrano, S. V., Matveev, V. B., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70479-0 · Cited by 231
A specific requirement for PDGF-C in palate formation and PDGFR-α signaling
Ding, H., Wu, X., Boström, H., Kim, I., Wong, N., Tsoi, B., O'Rourke, M., Koh, G. Y., Soriano, P., Betsholtz, C., et al. (2004) · Nature Genetics · doi:10.1038/ng1415 · Cited by 231
Crystal structure of human platelet-derived growth factor BB.
Oefner, C., D'Arcy, A., Winkler, F. K., Eggimann, B., & Hosang, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05485.x · Cited by 231
Hye-Ryong Shim, A., Liu, H., Focia, P. J., Chen, X., Lin, P. C., & He, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000806107 · Cited by 193
Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
Cao, Y. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.002 · Cited by 190
Johnsson, A., Betsholtz, C., Heldin, C.-H., & Westermark, B. (1985) · Nature · doi:10.1038/317438a0 · Cited by 189
Novel PDGF family members: PDGF-C and PDGF-D
Li, X., & Eriksson, U. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00090-4 · Cited by 189
Pro-fibrogenic potential of PDGF-D in liver fibrosis
Borkham-Kamphorst, E., van Roeyen, C. R. C., Ostendorf, T., Floege, J., Gressner, A. M., & Weiskirchen, R. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.029 · Cited by 184
Novel delivery approaches for cancer therapeutics
Mitra, A. K., Agrahari, V., Mandal, A., Cholkar, K., Natarajan, C., Shah, S., Joseph, M., Trinh, H. M., Vaishya, R., Yang, X., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.067 · Cited by 183
PDGF and PDGF receptors in glioma
Nazarenko, I., Hede, S.-M., He, X., Hedrén, A., Thompson, J., Lindström, M. S., & Nistér, M. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.665097 · Cited by 183
Heldin, C.-H., & Lennartsson, J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009100 · Cited by 176
Self-citationMcCarty, M. F., Somcio, R. J., Stoeltzing, O., Wey, J., Fan, F., Liu, W., Bucana, C., & Ellis, L. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31334 · Cited by 175
Piette, F., Belmin, J., Vincent, H., Schmidt, N., Pariel, S., Verny, M., Marquis, C., Mely, J., Hugonot-Diener, L., Kinet, J.-P., et al. (2011) · Alzheimer's Research & Therapy · doi:10.1186/alzrt75 · Cited by 173
Banai, S., Wolf, Y., Golomb, G., Pearle, A., Waltenberger, J., Fishbein, I., Schneider, A., Gazit, A., Perez, L., Huber, R., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1960 · Cited by 173
Amplification of KIT, PDGFRA, VEGFR2, and EGFR in Gliomas
Puputti, M., Tynninen, O., Sihto, H., Blom, T., Mäenpää, H., Isola, J., Paetau, A., Joensuu, H., & Nupponen, N. N. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0085 · Cited by 171
Therapeutic targeting of liver inflammation and fibrosis by nanomedicine.
Bartneck, M., Warzecha, K. T., & Tacke, F. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2014.11.02 · Cited by 170
Liu, Y., Wang, Z., Kwong, S. Q., Lui, E. L. H., Friedman, S. L., Li, F. R., Lam, R. W. C., Zhang, G. C., Zhang, H., & Ye, T. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.035 · Cited by 168
Yoshida, S., Ikenaga, N., Liu, S. B., Peng, Z.-W., Chung, J., Sverdlov, D. Y., Miyamoto, M., Kim, Y. O., Ogawa, S., Arch, R. H., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.038 · Cited by 164
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
Lassman, A. B., Pugh, S. L., Gilbert, M. R., Aldape, K., Geinoz, S., Beumer, J. H., Christner, S. M., Komaki, R. U., DeAngelis, L. M., Gaur, R., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov011 · Cited by 157
Dresemann, G. P., Weller, M., Rosenthal, M. A., Wedding, U., Wagner, W., Engel, E., Heinrich, B., Mayer‐Steinacker, R., Krarup‐Hansen, A., Fluge, Ø., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9976-3 · Cited by 156
He, C., Medley, S. C., Hu, T., Hinsdale, M. E., Lupu, F., Virmani, R., & Olson, L. E. (2015) · Nature Communications · doi:10.1038/ncomms8770 · Cited by 156
Applications of Cell-Penetrating Peptides for Tumor Targeting and Future Cancer Therapies
Regberg, J., Srimanee, A., & Langel, Ü. (2012) · Pharmaceuticals · doi:10.3390/ph5090991 · Cited by 155
Pontén, A., Li, X., Thorén, P., Aase, K., Sjöblom, T., Östman, A., & Eriksson, U. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63694-2 · Cited by 154
Variability in bioavailability of small molecular tyrosine kinase inhibitors
Herbrink, M., Nuijen, B., Schellens, J. H. M., & Beijnen, J. H. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.03.005 · Cited by 149
Jackson, E., & Lu, H. (2016) · Integrative Biology · doi:10.1039/c6ib00039h · Cited by 146
Boström, H., Gritli-Linde, A., & Betsholtz, C. (2001) · Developmental Dynamics · doi:10.1002/dvdy.1225 · Cited by 142
Imatinib Attenuates Diabetes-Associated Atherosclerosis
Lassila, M., Allen, T. J., Cao, Z., Thallas, V., Jandeleit-Dahm, K. A. M., Candido, R., & Cooper, M. E. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000124105.39900.db · Cited by 142
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
Vermersch, P., Benrabah, R., Schmidt, N., Zéphir, H., Clavelou, P., Vongsouthi, C., Dubreuil, P. C., Moussy, A., & Hermine, O. (2012) · BMC Neurology · doi:10.1186/1471-2377-12-36 · Cited by 140
Kim, Y., Kim, E. H., Wu, Q., Guryanova, O. A., Hitomi, M., Lathia, J. D., Serwanski, D. R., Sloan, A. E., Weil, R. J., Lee, J., et al. (2012) · Genes & Development · doi:10.1101/gad.193565.112 · Cited by 140
Skihar, V., Silva, C., Chojnacki, A. K., Döring, A., Stallcup, W. B., Weiss, S., & Yong, V. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909607106 · Cited by 126
PDGF-C Is a Proinflammatory Cytokine that Mediates Renal Interstitial Fibrosis
Eitner, F., Diaeresis]cher, E. B., van Roeyen, C. R. C., Kunter, U., Rong, S., Seikrit, C., Villa, L., Boor, P., Fredriksson, L., Diaeresism, G. B. D., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007030290 · Cited by 124
A human brain tumor-derived PDGFR-α deletion mutant is transforming
Clarke, I. D., & Dirks, P. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206160 · Cited by 124
A Novel Signaling Axis of Matriptase/PDGF-D/β-PDGFR in Human Prostate Cancer
Ustach, C. V., Huang, W., Conley‐LaComb, M. K., Lin, C., Che, M., Abrams, J., & Kim, H.-R. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0511 · Cited by 124
Tang, Z., Arjunan, P., Lee, C., Li, Y., Kumar, A., Hou, X., Wang, B., Wardęga, P., Zhang, F., Dong, L., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20091704 · Cited by 123
Self-citationPDGFR‐α inhibition preserves blood‐brain barrier after intracerebral hemorrhage
Ma, Q., Huang, B., Khatibi, N. H., Rolland, W. B., Suzuki, H., Zhang, J. H., & Tang, J. (2011) · Annals of Neurology · doi:10.1002/ana.22549 · Cited by 120
Platelet-derived growth factor receptor-α: a novel therapeutic target in human hepatocellular cancer
Stock, P., Monga, D. K., Tan, X., Micsenyi, A., Loizos, N., & Monga, S. P. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0720 · Cited by 120
Loizos, N., Xu, Y. C., Huber, J., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0114 · Cited by 118
Endothelial PDGF-CC regulates angiogenesis-dependent thermogenesis in beige fat
Seki, T., Hosaka, K., Lim, S., Fischer, C., Honek, J., Yang, Y., Andersson, P., Nakamura, M., Näslund, E. B., Ylä‐Herttuala, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12152 · Cited by 116
Parashar, A. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/18712.7922 · Cited by 114
Borkham‐Kamphorst, E., Kovalenko, E., van Roeyen, C. R. C., Gaßler, N., Bomble, M., Ostendorf, T., Floege, J., Gressner, A. M., & Weiskirchen, R. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.71 · Cited by 111
Hägglöf, C., Hammarsten, P., Josefsson, A., Stattin, P. E., Paulsson, J., Bergh, A. R. J., & Östman, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010747 · Cited by 109
Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson’s disease patients
Paul, G., Zachrisson, O., Varrone, A., Almqvist, P. M., Jerling, M., Lind, G., Rehncrona, S., Linderoth, B., Bjartmarz, H., Shafer, L. L., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79635 · Cited by 107
Kinnman, N., Goria, O., Wendum, D., Gendron, M., Rey, C., Poupon, R. Y., & Housset, C. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780384 · Cited by 105
PDGFβ Receptor Blockade Inhibits Intimal Hyperplasia in the Baboon
Hart, C. E., Kraiss, L. W., Vergel, S., Gilbertson, D. G., Kenagy, R. D., Kirkman, T. R., Crandall, D. L., Tickle, S. P., Finney, H. M., Yarranton, G. T., et al. (1999) · Circulation · doi:10.1161/01.cir.99.4.564 · Cited by 100
Aono, Y., Kishi, M., Yokota, Y., Azuma, M., Kinoshita, K., Takezaki, A., Sato, S., Kawano, H., Kishi, J., Goto, H., et al. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0455oc · Cited by 98
Lombardi, G., Pambuku, A., Bellu, L., Farina, M., Puppa, A. D., Denaro, L., & Zagonel, V. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.01.018 · Cited by 97
Autocrine PDGF stimulation in malignancies
Heldin, C. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.658119 · Cited by 96
Ostendorf, T., van Roeyen, C. R. C., Peterson, J. D., Kunter, U., Eitner, F., Hamad, A. J., Chan, G., Jia, X., Macaluso, J., Bornstein, G. G., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000083393.00959.02 · Cited by 96
A Potential Oncogenic Activity of Platelet-Derived Growth Factor D in Prostate Cancer Progression
Ustach, C. V., Taube, M. E., Hurst, N. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3047 · Cited by 95
Kim, S.-J., Uehara, H., Yazıcı, S., Busby, J. E., Nakamura, T., He, J., Maya, M., Logothetis, C. J., Mathew, P. F., Wang, X., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj211 · Cited by 94
Mathew, P. F., Thall, P. F., Bucana, C. D., Oh, W. K., Morris, M. J., Jones, D., Johnson, M. M., Wen, S., Pagliaro, L. C., Tannir, N. M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1269 · Cited by 94
Borkham‐Kamphorst, E., Stoll, D., Gressner, A. M., & Weiskirchen, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.153 · Cited by 91
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term
Neef, M., Ledermann, M., Saegesser, H., Schneider, V., Widmer, N., Decosterd, L. A., Rochat, B., & Reichen, J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.015 · Cited by 91
Hou, X., Kumar, A., Lee, C., Wang, B., Arjunan, P., Dong, L., Maminishkis, A., Tang, Z., Yang, L., Zhang, F., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004143107 · Cited by 83
Self-citationLeppänen, O., Janjić, N., Carlsson, M.-A., Pietras, K., Levin, M., Vargeese, C., Green, L. S., Bergqvist, D., Östman, A., & Heldin, C. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.e89 · Cited by 82
Velghe, A. I., Cauwenberghe, S. V., Polyansky, A. A., Chand, D., Montano‐Almendras, C. P., Charni, S., Hallberg, B., Essaghir, A., & Demoulin, J. (2013) · Oncogene · doi:10.1038/onc.2013.218 · Cited by 80
Giese, N. A., Marijianowski, M. M. H., McCook, O., Hancock, A., Ramakrishnan, V., Fretto, L. J., Chen, C., Kelly, A. B., Koziol, J. A., Wilcox, J. N., et al. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.900 · Cited by 80
Nordby, Y., Richardsen, E. H., Rakaee, M., Ness, N., Dønnem, T., Patel, H., Busund, L., Bremnes, R. M., & Andersen, S. (2017) · Scientific Reports · doi:10.1038/srep43378 · Cited by 76
Kumabe, T., SOHMA, Y., Kayama, T., Yoshimoto, T., & Yamamoto, T. (1992) · PubMed · Cited by 75
Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis
Zhuo, Y., Zhang, J., Laboy, M., et al. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00083.2003 · Cited by 73
LaRochelle, W. J., Jeffers, M., Corvalán, J. R. F., Jia, X., Feng, X. S., Vanegas, S., Vickroy, J. D., Yang, X., Chen, F., Gazit, G., et al. (2002) · PubMed · Cited by 73
Watzlawik, J. O., Warrington, A. E., & Rodriguez, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055149 · Cited by 72
Bonner, J. C., Goodell, A. L., Coin, P. G., & Brody, A. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116584 · Cited by 69
Lindroos, P. M., Coin, P. G., Badgett, A., Morgan, D. L., & Bonner, J. C. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.3.9070613 · Cited by 69
Role of PDGF-D and PDGFR-β in neuroinflammation in experimental ICH mice model
Yang, P., Manaenko, A., Xu, F., Miao, L., Wang, G., Hu, X., Guo, Z., Hu, Q., Hartman, R. E., Pearce, W. J., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.010 · Cited by 69
Targeting the PDGF Signaling Pathway in the Treatment of Non-Malignant Diseases
Heldin, C. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9484-2 · Cited by 68
Ninomiya, K., Yamashita, T., Kawabata, S., & Shimizu, N. (2014) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2013.12.023 · Cited by 67
IMATINIB MESYLATE INHIBITS FIBROGENESIS IN ASBESTOS-INDUCED INTERSTITIAL PNEUMONIA
Vuorinen, K., Gao, F., Oury, T. D., Kinnula, V. L., & Myllärniemi, M. (2007) · Experimental Lung Research · doi:10.1080/01902140701634827 · Cited by 62
Platelet-derived growth factor in glioblastoma—driver or biomarker?
Westermark, B. (2014) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2014.970304 · Cited by 61
Strittmatter, K., Pomeroy, H., & Marneros, A. G. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.02.018 · Cited by 61
Martin, I. V., Borkham‐Kamphorst, E., Zok, S., van Roeyen, C. R. C., Eriksson, U., Boor, P., Hittatiya, K., Fischer, H., Wasmuth, H. E., Weiskirchen, R., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.09.006 · Cited by 60
Pennock, S., & Kazlauskas, A. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06668-11 · Cited by 60
Masuda, S., Nakano, K., Funakoshi, K., Zhao, G., Meng, W., Kimura, S., Matoba, T., Miyagawa, M., Iwata, E., Sunagawa, K., et al. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.8730 · Cited by 58
Lewandowski, S. A., Fredriksson, L., Lawrence, D. A., & Eriksson, U. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.016 · Cited by 58
Shaker, M. E., Salem, H. A., Shiha, G. E.-S., & Ibrahim, T. M. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00824.x · Cited by 57
Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A
Thieringer, F. R., Maass, T., Czochra, P., Klopcic, B. R. S., Conrad, I., Friebe, D., Schirmacher, P., Lohse, A. W., Blessing, M., Galle, P. R., et al. (2008) · Gene · doi:10.1016/j.gene.2008.05.022 · Cited by 57
Li, J., & Hoyle, G. W. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0441 · Cited by 56
Paulsson, J., Lindh, M. B., Jarvius, M., Puputti, M., Nistér, M., Nupponen, N. N., Paulus, W., Söderberg, O., Dresemann, G. P., von Deimling, A., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25528 · Cited by 54
Musa, H., Kaur, K., O’Connell, R. P., Klos, M., Guerrero‐Serna, G., Avula, U. M. R., Herron, T. J., Kalifa, J., ANUMONWO, J. M. B., & Jalife, J. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.03.014 · Cited by 54
Ikura, Y., Morimoto, H., Ogami, M., Jomura, H., Ikeoka, N., & Sakurai, M. (1997) · Journal of Gastroenterology · doi:10.1007/bf02934089 · Cited by 54
Fredriksson, L., Nilsson, I., Su, E. J., Andræ, J., Ding, H., Betsholtz, C., Eriksson, U., & Lawrence, D. A. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.12.006 · Cited by 54
Yamasaki, Y., Miyoshi, K., Oda, N., Watanabe, M., Miyake, H., Chan, J., Wang, X., Sun, L., Tang, C., McMahon, G., et al. (2001) · Circulation Research · doi:10.1161/01.res.88.6.630 · Cited by 54
Chen, P., Unger, V. M., & He, X. L. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.10.003 · Cited by 51
Wagner, A. J., Kindler, H. L., Gelderblom, H. A. J., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw659 · Cited by 50
Systematic Review and Network Meta-analysis of Idiopathic Pulmonary Fibrosis Treatments
Fleetwood, K., McCool, R., Glanville, J., Edwards, S. C., Gsteiger, S., Daigl, M., & Fisher, M. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.3-b.s5 · Cited by 49
Upregulation of the PDGF-alpha Receptor Precedes Asbestos-induced Lung Fibrosis in Rats
Lasky, J. A., Tonthat, B., Liu, J., Friedman, M. B., & Brody, A. R. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9704116 · Cited by 49
Egawa-Tsuzuki, T., Ohno, M., Tanaka, N., Takeuchi, Y., Uramoto, H., Faigle, R., Funa, K., Ishii, Y., & Sasahara, M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.11.001 · Cited by 49
The role of growth factors as a therapeutic approach to demyelinating disease
Huang, Y., & Dreyfus, C. F. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.02.023 · Cited by 47
Olaratumab: First Global Approval
Shirley, M. (2016) · Drugs · doi:10.1007/s40265-016-0680-2 · Cited by 47
Therapeutic targeting of platelet-derived growth factor receptors in solid tumors
Ehnman, M., & Östman, A. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.847086 · Cited by 46
Pathogenetic significance and possibility as a therapeutic target of platelet derived growth factor
Ishii, Y., Hamashima, T., Yamamoto, S., & Sasahara, M. (2017) · Pathology International · doi:10.1111/pin.12530 · Cited by 45
Zhan, Y., Krafft, P. R., Lekic, T., Ma, Q., Souvenir, R., Zhang, J. H., & Tang, J. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23475 · Cited by 44
Brody, A. R., Liu, J. Y., Brass, D., & Corti, M. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s51165 · Cited by 44
Russell, M. R., Liu, Q., & Fatatis, A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1863 · Cited by 44
Benezra, M., Hambardzumyan, D., Medina, O. P., Veach, D. R., Pillarsetty, N., Smith-Jones, P. M., Phillips, E. H., Ozawa, T., ZANZONICO, P. B., Longo, V. A., et al. (2012) · Neoplasia · doi:10.1593/neo.121750 · Cited by 43
Gerber, D. E., Gupta, P. K., Dellinger, M. T., Toombs, J. E., Peyton, M., Duignan, I. J., Malaby, J., Bailey, T., Burns, C. A., Brekken, R. A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0431 · Cited by 43
Lewis, N. E. O. C. D., Olson, N. E., & Elaine, W. (2001) · Platelets · doi:10.1080/09537100120071013 · Cited by 43
Shiha, G. E.-S., Abu‐Elsaad, N., Zalata, K. R., & Ibrahim, T. M. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12286 · Cited by 39
Cortez, E., Gladh, H., Braun, S. B., Bocci, M., Cordero, E., Björkström, N. K., Miyazaki, H., Michael, I. P., Eriksson, U., Folestad, E. B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509384113 · Cited by 39
Andræ, J., Gouveia, L., Gallini, R., He, L., Fredriksson, L., Nilsson, I., Johansson, B. R., Eriksson, U., & Betsholtz, C. (2016) · Biology Open · doi:10.1242/bio.017368 · Cited by 39
Akagi, S., Nakamura, K., Miura, D., Saito, Y., Matsubara, H., Ogawa, A., Matoba, T., Egashira, K., & Ito, H. (2015) · International Heart Journal · doi:10.1536/ihj.14-338 · Cited by 38
Phase I trial of dovitinib (TKI258) in recurrent glioblastoma
Schäfer, N., Gielen, G. H., Kebir, S., Wieland, A., Till, A., Mack, F., Schaub, C., Tzaridis, T., Reinartz, R., Nießen, M., et al. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2161-0 · Cited by 38
Rosenberg, A. S., & Mathew, P. F. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.787409 · Cited by 37
Inhibitory effect of soluble PDGF-β receptor in culture-activated hepatic stellate cells
Borkham‐Kamphorst, E., Stoll, D., Gressner, A. M., & Weiskirchen, R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.064 · Cited by 35
Huang, W., Fridman, Y., Bonfil, R. D., Ustach, C. V., Conley‐LaComb, M. K., Wiesner, C., Saliganan, A. D., Cher, M. L., & Kim, H.-R. C. (2011) · Oncogene · doi:10.1038/onc.2011.573 · Cited by 35
Kuai, J., Mosyak, L., Brooks, J., Cain, M., Carven, G. J., Ogawa, S., Ishino, T., Tam, M., LaVallie, E. R., Yang, Z., et al. (2015) · Biochemistry · doi:10.1021/bi5015425 · Cited by 33
Aljuffali, I. A., Pan, T., Sung, C. T., Chang, S., & Fang, J. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.04.009 · Cited by 30
Zohlnhöfer, D., Hausleiter, J., Kastrati, A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.060 · Cited by 29
Hao, Z., Fan, X.-B., Li, S., Lv, Y., Su, H., Jiang, H., & Li, H.-H. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194357 · Cited by 19
Yu, J., Rupasinghe, C. N., Wilson, J. L., Taylor, L., Rahimi, N., Mierke, D. F., & POLGAR, P. R. (2014) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12446 · Cited by 16
Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient
Salvadó, M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i36.10475 · Cited by 16
Zheng, L., Zhao, C., Du, Y., Lin, X., Jiang, Y., Lee, C., Tian, G., Mi, J., Li, X., Chen, Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12843 · Cited by 15
Analogs, formulations and derivatives of imatinib: a patent review
Musumeci, F., Schenone, S., Grossi, G., Brullo, C., & Sanna, M. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1089233 · Cited by 14
Armstrong, A. J., Halabi, S., Healy, P. N., Lee, W. R., Koontz, B. F., Moul, J. W., Mundy, K., Creel, P. A., Wood, S., Davis, K., et al. (2016) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2015.59 · Cited by 14
Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?
Mace, M. L., Dahl, J., & Jabbour, E. J. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1031107 · Cited by 12
Application of CPPs for Brain Delivery
Srimanee, A., Regberg, J., & Langel, Ü. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2806-4_23 · Cited by 11
The Evolution of Tumor‐Targeted Drug Delivery: From the EPR Effect to Nanoswimmers
Zoaby, N., Golani‐Armon, A., Zinger, A., Reshef, M., Yaari, Z. A., Vardi‐Oknin, D., Shatsberg, Z., Shomar, A., Shainsky‐Roitman, J., & Schroeder, A. (2013) · Israel Journal of Chemistry · doi:10.1002/ijch.201300061 · Cited by 9
Cited by
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Targeting fibrosis: mechanisms and clinical trials
Zhao, M., Wang, L., Wang, M., Zhou, S., Lu, Y., Cui, H., Racanelli, A. C., Zhang, L., Ye, T., Ding, B., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01070-3 · Cited by 547
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Zheng, J., Wang, S., Xia, L., Sun, Z., Chan, K. M., Bernards, R., Qin, W., Chen, J., Xia, Q., & Jin, H. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02075-w · Cited by 341
Effect of Stromal Cells in Tumor Microenvironment on Metastasis Initiation
Guo, S., & Deng, C.-X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25720 · Cited by 315
Tap, W. D., Wagner, A. J., Schöffski, P., Martin-Broto, J., Krarup-Hansen, A., Ganjoo, K. N., Yen, C.-C., Abdul Razak, A. R., Spira, A., Kawai, A., et al. (2020) · JAMA · doi:10.1001/jama.2020.1707 · Cited by 309
Metadata
- Authors
- Papadopoulos, N., & Lennartsson, J.
- Venue
- Molecular Aspects of Medicine
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 62
- Pages
- 75-88
- ISSN
- 0098-2997 (ISSN-L)
- OpenAlex
- W2769616494
- Cited by
- 283
- References
- 171
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.